Ginell R. Post

High Impact

Professor

UAMS

Last publication 2025 Last refreshed 2026-05-16

faculty

Pathology, College of Medicine

21 h-index 128 pubs 1,758 cited

Research Areas

Links

ORCID Lab Website Research Group UAMS TRI Profile

OverviewAI-generated summary

Ginell R. Post's research focuses on hematopathology, with a specific emphasis on coagulopathies associated with cancer and inflammation. Utilizing molecular-genetic and immunohistochemical techniques, Post investigates the pathobiology of hematopoietic diseases. This work includes studies on the classification and understanding of these conditions.

Post's research has explored various aspects of hematologic malignancies and related complications. Publications include investigations into the role of specific genes in DNA recombination relevant to immune responses, the identification of NEK2 as a therapeutic target in lymphoma, and the presentation of Hairy Cell Leukemia as severe acute respiratory distress syndrome. Additionally, research has touched upon the evaluation of novel drug delivery systems and the immune responses induced by experimental vaccines in breast cancer patients.

With an h-index of 21 and over 129 publications, Post is recognized as a highly cited researcher. Key collaborators at the University of Arkansas for Medical Sciences include Vijay Patel, Sydnye L. Shuttleworth, Samantha Kendrick, and Syed Hassan Mehdi, with whom Post shares 39 co-authored publications, indicating a strong collaborative network within the institution.

Research Overview

My current clinical and research interests are in the area of hematopathology with focus on cancer- and inflammation-related coagulopathies and use molecular-genetic and immunohistochemical approaches to classify and understand the pathobiology of hematopoietic diseases.

Metrics

h-index: 21
Publications: 128
Citations: 1,758

Selected Publications

Hairy Cell Leukemia (HCL) Presenting As Severe Acute Respiratory Distress Syndrome (ARDS) With Legionella pneumophila: Coincidence or Causation? (2023)

1 citation DOI OpenAlex
Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma (2023)

13 citations DOI OpenAlex
Rad52 mediates class-switch DNA recombination to IgD (2022)

DOI OpenAlex
Interaction of the Class A Scavenger Receptor with Multiple Myeloma Cells (2022)

DOI OpenAlex
Abstract P2-14-15: Timing of the immunization defines immune signature of a peptide cancer vaccine combined with Neoadjuvant chemotherapy in HR+ breast cancer patients (2022)

DOI OpenAlex
Intestinal T‐cell lymphoma: A rare entity presenting with severe acute upper quadrant pain (2022)

8 citations DOI OpenAlex
Analysis of Hematopoietic Niche Components Post Allogeneic Transplantation (2021)

DOI OpenAlex
P10s-PADRE vaccine combined with neoadjuvant chemotherapy in ER-positive breast cancer patients induces humoral and cellular immune responses (2021)

10 citations DOI OpenAlex
Rad52 mediates class-switch DNA recombination to IgD (2021)

DOI OpenAlex
Evaluation of bone and kidney toxicity of BT2-peg2, a potential carrier for the targeted delivery of antibiotics to bone (2021)

2 citations DOI OpenAlex